BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 33321708)

  • 1. Carotenoids in Cancer Metastasis-Status Quo and Outlook.
    Koklesova L; Liskova A; Samec M; Zhai K; Abotaleb M; Ashrafizadeh M; Brockmueller A; Shakibaei M; Biringer K; Bugos O; Najafi M; Golubnitschaja O; Büsselberg D; Kubatka P
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33321708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells.
    Gupta R; Chetty C; Bhoopathi P; Lakka S; Mohanam S; Rao JS; Dinh DE
    Int J Oncol; 2011 Mar; 38(3):733-44. PubMed ID: 21181094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Carotene inhibits neuroblastoma cell invasion and metastasis in vitro and in vivo by decreasing level of hypoxia-inducible factor-1α.
    Kim YS; Lee HA; Lim JY; Kim Y; Jung CH; Yoo SH; Kim Y
    J Nutr Biochem; 2014 Jun; 25(6):655-64. PubMed ID: 24746828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crocin inhibits the migration, invasion, and epithelial-mesenchymal transition of gastric cancer cells via miR-320/KLF5/HIF-1α signaling.
    Zhou Y; Xu Q; Shang J; Lu L; Chen G
    J Cell Physiol; 2019 Aug; 234(10):17876-17885. PubMed ID: 30851060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia Promotes Extravillous Trophoblast Cell Invasion through the Hypoxia-Inducible Factor Urokinase-Type Plasminogen Activator Receptor Pathway.
    Shigemitsu A; Naruse K; Kobayashi H
    Gynecol Obstet Invest; 2022; 87(3-4):232-241. PubMed ID: 35785760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors.
    Mauro CD; Pesapane A; Formisano L; Rosa R; D'Amato V; Ciciola P; Servetto A; Marciano R; Orsini RC; Monteleone F; Zambrano N; Fontanini G; Servadio A; Pignataro G; Grumetto L; Lavecchia A; Bruzzese D; Iaccarino A; Troncone G; Veneziani BM; Montuori N; Placido S; Bianco R
    Sci Rep; 2017 Aug; 7(1):9388. PubMed ID: 28839232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking MMP-12-modulated epithelial-mesenchymal transition by repurposing penfluridol restrains lung adenocarcinoma metastasis via uPA/uPAR/TGF-β/Akt pathway.
    Hung WY; Lee WJ; Cheng GZ; Tsai CH; Yang YC; Lai TC; Chen JQ; Chung CL; Chang JH; Chien MH
    Cell Oncol (Dordr); 2021 Oct; 44(5):1087-1103. PubMed ID: 34319576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-β, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition.
    Santibanez JF; Obradović H; Kukolj T; Krstić J
    Dev Dyn; 2018 Mar; 247(3):382-395. PubMed ID: 28722327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The urokinase plasminogen activator system in breast cancer invasion and metastasis.
    Tang L; Han X
    Biomed Pharmacother; 2013 Mar; 67(2):179-82. PubMed ID: 23201006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of urokinase receptor in tumor progression and development.
    Noh H; Hong S; Huang S
    Theranostics; 2013; 3(7):487-95. PubMed ID: 23843896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming Growth Factor-Beta and Urokinase Type Plasminogen Interplay in Cancer.
    Santibanez JF; Krstic J
    Curr Protein Pept Sci; 2018; 19(12):1155-1163. PubMed ID: 29086689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plantamajoside inhibits the proliferation and epithelial-to-mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia-inducible factor-1α-dependent gene expression.
    Yin W; Xu J; Li C; Dai X; Wu T; Wen J
    Cell Biol Int; 2020 Aug; 44(8):1616-1627. PubMed ID: 32239594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of uPAR promotes urokinase translocation into the nucleus and epithelial to mesenchymal transition in neuroblastoma.
    Semina EV; Rubina KA; Shmakova AA; Rysenkova KD; Klimovich PS; Aleksanrushkina NA; Sysoeva VY; Karagyaur MN; Tkachuk VA
    J Cell Physiol; 2020 Sep; 235(9):6268-6286. PubMed ID: 31990070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
    Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
    J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The urokinase-type plasminogen activator system and its role in tumor progression].
    Kugaevskaya EV; Gureeva TA; Timoshenko OS; Solovyeva NI
    Biomed Khim; 2018 Nov; 64(6):472-486. PubMed ID: 30632975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
    Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
    Int J Cancer; 2002 Dec; 102(4):379-89. PubMed ID: 12402308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
    Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
    Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.
    Pavón MA; Arroyo-Solera I; Céspedes MV; Casanova I; León X; Mangues R
    Oncotarget; 2016 Aug; 7(35):57351-57366. PubMed ID: 27385000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JNK suppression is essential for 17β-Estradiol inhibits prostaglandin E2-Induced uPA and MMP-9 expressions and cell migration in human LoVo colon cancer cells.
    Hsu HH; Hu WS; Lin YM; Kuo WW; Chen LM; Chen WK; Hwang JM; Tsai FJ; Liu CJ; Huang CY
    J Biomed Sci; 2011 Aug; 18(1):61. PubMed ID: 21859479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of matrixmetalloproteinases in the tumor growth and metastasis].
    Velinov N; Poptodorov G; Gabrovski N; Gabrovski S
    Khirurgiia (Sofiia); 2010; (1):44-9. PubMed ID: 21972705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.